NASDAQ

Vir Biotechnology, Inc. (VIR)

♥ 707 Thanks from members

Live price chart, market sentiment, and community perspectives for Vir Biotechnology, Inc. (NASDAQ: VIR).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: Health CareIndustry: BiotechnologyFounder: Venture Firm Arch Venture PartnersLeadership: Vicki Sato (Chairman)Leadership: Vir Leadership TeamHolder: SoftBank GroupHolder: Arch Venture PartnersHolder: Fidelity ManagementImmunology TherapeuticsInfectious Disease TreatmentsMonoclonal Antibodies#VIR#Vir Biotechnology#Immunology#Biotech stock#NASDAQ